AbbVie bucks Puerto Rico departure trend with $30m expansion
AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.
AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.
Takeda has licensed technology from ImmunoGen to make two antibody drug conjugates (ADCs) targeting cancer.
update
Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.
Sourcing human beta cells may soon no longer be a challenge for AstraZeneca diabetes researchers thanks to a new partnership with stem cell scientists at Harvard University.